Efficacy of mindfulness added to treatment as usual in patients with chronic migraine and medication overuse headache: a phase-III single-blind randomized-controlled trial (the MIND-CM study)
Open accessThe DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
Background: Mindfulness gained considerable attention for migraine management, but RCTs are lacking. We aimed to assess the efficacy of a six-sessions mindfulness-based treatment added to treatment as usual (TaU) in patients with Chronic Migraine (CM) and Medication Overuse Headache (MOH) on headache frequency, medication intake, quality of life, disability, depression and anxiety, cutaneous allodynia, awareness of inner states, work-related difficulties, and disease cost. Methods: In this Phase-III single-blind RCT carried out in a specialty Italian headache center, 177 patients with CM and MOH were randomized 1:1 to either TaU (withdrawal from overused drugs, education on proper medication use and lifestyle issues, and tailored prophylaxis) or mindfulness-based intervention added to TaU (TaU + MIND). The mindfulness-based intervention consisted of six group session of mindfulness practice and 7–10 min daily self-practice. The primary endpoint was the achievement of ≥ 50% headache frequency reduction at 12 months compared to baseline, and was analyzed on an intention-to-treat principle using Pearson’s Chi-Squared test. Secondary endpoints included medication intake, quality of life (QoL), disability, depression and anxiety, cutaneous allodynia, awareness of inner states, work-related difficulties, and disease cost. The secondary endpoints were analyzed using per-protocol linear mixed models. Results: Out of the 177 participants 89 were randomized to TaU and 88 to TaU + MIND. Patients in the TaU + MIND group outperformed those in TaU for the primary endpoint (78.4% vs. 48.3%; p < 0.0001), and showed superior improvement in headache frequency, QoL and disability, headache impact, loss of productive time, medication intake, and in total, indirect and direct healthcare costs. Conclusions: A mindfulness-based treatment composed of six-week session and 7–10 min daily self-practice added on to TaU is superior to TaU alone for the treatment of patients with CM and MOH. Trial registration: MIND-CM was registered on clinicaltrials.gov (NCT03671681) on14/09/2018.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Grazzi et al. (2023) reported notable improvements in headache-related disability and quality of life following MBSR, reinforcing its therapeutic value.”
From The effectiveness of mindfulness as a complementary therapy in headache patients: a preliminary interventional study (2025) · cites this paper as Grazzi et al. (2023)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The benefits of being present: Mindfulness and its role in psychological well-being
Brown, K. W., & Ryan, R. M. (2003) · Journal of Personality and Social Psychology · doi:10.1037/0022-3514.84.4.822 · Cited by 13,448 · cited 4×
“1) [12, 13]; disability, assessed by the Migraine Disability Assessment (MIDAS) [14, 15], and by the 12-item WHO Disability Assessment Schedule (WHODAS-12) [16]; headache impact, assessed by the six-item Headache Impact Test (HIT-6) [17]; symptoms of depression and anxiety, assessed by the Beck Depression InventoryII…”
MethodInfluentialDeveloping the World Health Organization Disability Assessment Schedule 2.0
Üstün, T. B., Chatterji, S., Kostanjsek, N., Rehm, J., Kennedy, C., Epping-Jordan, J., Saxena, S., von Korff, M., & Pull, C. (2010) · Bulletin of the World Health Organization · doi:10.2471/blt.09.067231 · Cited by 1,851
A six-item short-form survey for measuring headache impact: The HIT-6™
Kosinski, M., Bayliss, M. S., Bjorner, J. B., Ware, J. E., Garber, W. H., Batenhorst, A., Cady, R., Dahlöf, C. G. H., Dowson, A., & Tepper, S. (2003) · Quality of Life Research · doi:10.1023/a:1026119331193 · Cited by 1,376 · cited 11×
“Patients in the TaU + MIND group achieved significantly better results than those in TaU for the achievement of HIT-6 clinically meaningful reduction at each follow-up (see Supplementary Table 1 in Additional file 2).”
MethodInfluentialThe cost of headache disorders in Europe: the Eurolight project
Linde, M., Gustavsson, A., Stovner, L. J., Steiner, T. J., Barré, J., Katsarava, Z., Lainez, J. M., Lampl, C., Lantéri‐Minet, M., Rastenyte, D., et al. (2012) · European Journal of Neurology · doi:10.1111/j.1468-1331.2011.03612.x · Cited by 741 · cited 1×
“The greater improvement in LPT is clearly connected to the superior improvement in indirect cost, which represents the largest part of migraine-associated costs [25, 36, 37].”
BackgroundChronic migraine: risk factors, mechanisms and treatment
May, A., & Schulte, L. H. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.93 · Cited by 630 · cited 1×
“This is of relevance, considering medication overuse role in migraine chronification [38, 39], and that tackling the pain-pill automatism is a core content of our mindfulness protocol: the effect is evident as those in the TaU + MIND group reduced the amount of intakes per headache day by approximately 23% (from 2.”
BackgroundCutaneous allodynia in the migraine population
Lipton, R. B., Bigal, M. E., Ashina, S., Burstein, R., Silberstein, S., Reed, M. L., Serrano, D., Stewart, W. F., & American Migraine Prevalence Prevention Advisory Group (2008) · Annals of Neurology · doi:10.1002/ana.21211 · Cited by 598 · cited 3×
“1) [12, 13]; disability, assessed by the Migraine Disability Assessment (MIDAS) [14, 15], and by the 12-item WHO Disability Assessment Schedule (WHODAS-12) [16]; headache impact, assessed by the six-item Headache Impact Test (HIT-6) [17]; symptoms of depression and anxiety, assessed by the Beck Depression InventoryII…”
MethodValidity and Reliability of the Migraine‐Specific Quality of Life Questionnaire (MSQ Version 2.1)
Martin, B. C., Pathak, D. S., Sharfman, M. I., Adelman, J. U., Taylor, F., Kwong, W. J., & Jhingran, P. (2000) · Headache: The Journal of Head and Face Pain · doi:10.1046/j.1526-4610.2000.00030.x · Cited by 299
A narrative review on the burden of migraine: when the burden is the impact on people’s life
Leonardi, M., & Raggi, A. (2019) · The Journal of Headache and Pain · doi:10.1186/s10194-019-0993-0 · Cited by 289 · cited 1×
“Patients with CM and MOH experience relevant pain, limitations in daily activities, personal and societal disease burden [2].”
BackgroundSelf-citationWells, R. E., O’Connell, N., Pierce, C. R., Estave, P., Penzien, D. B., Loder, E., Zeidan, F., & Houle, T. T. (2021) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2020.7090 · Cited by 183
Research works printed but not linked: 4
- Beck AT, Steer RA, Brown GK (1996) Beck depression inventory manual, 2nd edn. The Psychological Corporation, Harcourt, Brace & Company, San Antonio (TX)
- Ghisi M, Flebus GB, Montano A, Sanavio E, Sica C (2006) Beck Depression Inventory-II. Manuale Italiano. Organizzazioni Speciali, Firenze
- Spielberger CD (1989) State-trait anxiety inventory: bibliography, 2nd edn. Consulting Psychologists Press, Palo Alto (CA)
- Predabissi L, Santinello M (1989) Inventario per l’ansia di stato e di tratto Nuova versione italiana dello S.T.A.I. – forma Y. Organizzazioni Speciali, Firenze
Cited by
Hallmarks of primary headache: part 1 – migraine
Raggi, A., Leonardi, M., Arruda, M., Caponnetto, V., Castaldo, M., Coppola, G., Della Pietra, A., Fan, X., Garcia-Azorin, D., Gazerani, P., et al. (2024) · The Journal of Headache and Pain · doi:10.1186/s10194-024-01889-x · Cited by 198
Self-citationLeonardi, M., Martelletti, P., Burstein, R., Fornari, A., Grazzi, L., Guekht, A. B., Lipton, R. B., Mitsikostas, D. D., Olesen, J., Owolabi, M. O., et al. (2024) · The Journal of Headache and Pain · doi:10.1186/s10194-023-01700-3 · Cited by 86
Self-citationMedication-overuse headache: a narrative review
Gosalia, H., Moreno‐Ajona, D., & Goadsby, P. J. (2024) · The Journal of Headache and Pain · doi:10.1186/s10194-024-01755-w · Cited by 65
Fedeli, D., Ciullo, G., Demichelis, G., Medina, J. P., Bruzzone, M. G., Ciusani, E., Erbetta, A., Ferraro, S., Grisoli, M., Guastafierro, E., et al. (2024) · The Journal of Headache and Pain · doi:10.1186/s10194-024-01803-5 · Cited by 17
“Since our sample is part of the larger cohort tested by Grazzi et al. [11], our positive clinical findings should be interpreted considering the beneficial effects of the combined TaU + MIND treatment previously reported.”
BackgroundMethodResultInfluentialSelf-citationAdvances in migraine prevention
Martinelli, D., Icco, R. D., Al‐Khazali, H. M., Ashina, S., Diener, H., Dodd-Glover, F., Goicochea, M. T., Jenkins, B., MaassenVanDenBrink, A., Lee, M. J., et al. (2026) · The Lancet Neurology · doi:10.1016/s1474-4422(25)00477-6 · Cited by 16
Metadata
- Authors
- Grazzi, L., D’Amico, D., Guastafierro, E., Demichelis, G., Erbetta, A., Fedeli, D., Nigri, A., Ciusani, E., Barbara, C., & Raggi, A.
- Affiliations
- Fondazione IRCCS Istituto Neurologico Carlo Besta (IT)
- Corresponding author
- Raggi, Alberto
- ORCID
- Venue
- The Journal of Headache and Pain
- Published
- 2023-07-14
- Volume
- 24
- Issue
- 1
- Pages
- 86-86
- ISSN
- 1129-2369 (ISSN-L)
- 1129-2377
- PMC
- PMC10347788
- OpenAlex
- W4384340173
- Cited by
- 34
- References
- 37
- Citations by year
- 2026: 6 · 2025: 17 · 2024: 10 · 2023: 1
- FWCI
- 6.92
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- The Journal of Headache and Pain (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Ministero della Salute (RF-2016-02364801)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Migraine and Headache Studies
- Social Sciences › Psychology › Clinical Psychology › Mindfulness and Compassion Interventions
- Health Sciences › Dentistry › Oral Surgery › Temporomandibular Joint Disorders
- Keywords
- mindfulness-based interventions, chronic migraine, medication overuse headache, headache frequency, drug withdrawal, quality of life, disability, anxiety and depression, cutaneous allodynia, health care costs, work-related difficulties, headache prevention
- MeSH terms
- Headache, Humans, Hyperalgesia, Migraine Disorders, Quality of Life, Single-Blind Method, Treatment Outcome, Headache Disorders, Secondary, Mindfulness
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Efficacy of mindfulness added to treatment as usual in patients with chronic migraine and medication overuse headache: a phase-III single-blind randomized-controlled trial (the MIND-CM study). https://app.cochat.ai/papers/10.1186/s10194-023-01630-0
- The paper
- Grazzi, L., D’Amico, D., Guastafierro, E., Demichelis, G., Erbetta, A., Fedeli, D., Nigri, A., Ciusani, E., Barbara, C., & Raggi, A. (2023). Efficacy of mindfulness added to treatment as usual in patients with chronic migraine and medication overuse headache: a phase-III single-blind randomized-controlled trial (the MIND-CM study). The Journal of Headache and Pain. https://doi.org/10.1186/s10194-023-01630-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.